Latest Breaking News On - Joshua phillipson - Page 1 : comparemela.com

Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Görlich on Louis-Jeantet Prize

/PRNewswire/ Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on development of inflammation and immunology (I&I).

Israel generalAmir reichmanMatthias dobbelsteinTamar ben yedidiaJoshua phillipsonScinai immunotherapeuticsMax planck institute for multidisciplinary sciencesCompany contactAntiviral researchPrnewswire scinai immunotherapeutics ltdUniversity medical centerScinai immunotherapeutics ltdMax planck instituteMultidisciplinary sciencesHeinz maier leibnitz prizeAlfried krupp prize

Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1 69 Million in Gross Proceeds

Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1 69 Million in Gross Proceeds
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Israel generalUnited statesJoshua phillipsonScinai immunotherapeuticsScinai immunotherapeutics ltdExchange commissionHc wainwright coCompany annual report on formEuropean investment bankCompany contactOutstanding warrantsDepositary sharesSecurities actPrivate litigation reform actAnnual report

Scinai Immunotherapeutics CEO Issues Letter To Shareholders

Scinai Immunotherapeutics CEO Issues Letter To Shareholders
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Israel generalScinai nanoabsScinai bioservicesScinai immunotherapeuticsMax planckJoshua phillipsonAmir reichmanAmos gilharPrnewswire scinai immunotherapeutics ltdIsrael innovation authorityEuropean investment bankCompany contactTechnion israel institute of scienceScinai immunotherapeutics ltdScinai shareholdersTechnion israel institute

Scinai Immunotherapeutics (SCNI) CEO Issues Letter to Shareholders

Scinai Immunotherapeutics (SCNI) CEO Issues Letter to Shareholders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Amir reichmanScinai bioservicesAmos gilharJoshua phillipsonScinai nanoabsMax planckScinai immunotherapeutics ltdTechnion israel institute of scienceEuropean investment bankIsrael innovation authorityScinai shareholdersTechnion israel instituteInvestor relations director

Scinai Immunotherapeutics CEO Issues Letter to Shareholders

JERUSALEM , Jan. 4, 2024 /PRNewswire/ Scinai Immunotherapeutics Ltd. , a biopharmaceutical company focused on development of inflammation and immunology biological products, today published a.

Israel generalAmir reichmanScinai bioservicesAmos gilharJoshua phillipsonScinai immunotherapeuticsScinai nanoabsMax planckEuropean investment bankIsrael innovation authorityScinai immunotherapeutics ltdPrnewswire scinai immunotherapeutics ltdCompany contactTechnion israel institute of scienceScinai shareholdersTechnion israel institute